Instructions for Vinpocetine 5 mg 50 pills
English product name
Vinpocetine
Release form
tab 5 mg: 20, 30 or 50 pcs
Description:
Tablets white or white with a yellowish color, flat-cylindrical with bevel and risk.
1 tab.
vinpocetine 5 mg
Auxiliary substances: lactose, silica colloid (aerosyl), potato starch, talc, magnesium stearate.
ATC codes
N06BX18 Vinpocetine
Clinical-pharmacological groups / Group affiliation
Drug that improves blood circulation and brain metabolism
Active substance
vinpocetine
Pharmacotherapy group:
Cerebrovasodilating agent
Testimony:
- Acute and chronic cerebral circulation failure.
- Discirculatory encephalopathy with memory impairment
- dizziness
- headache
- Post-traumatic encephalopathy.
- Vascular diseases of the retina and the vasculature of the eye
- Impaired hearing of vascular or toxic genesis
- Ménière's disease
- dizziness of labyrinthine origin
- Vegetative dystonia in climacteric syndrome
Method of use, course and dosage:
For ingestion - five to ten mg three times a day.
In the form of injections (mainly in acute conditions), the single dose is twenty mg, with good tolerability, the dose is increased for three to four days to one mg/kg; Duration of treatment ten - fourteen days.
Application in elderly patients
It is used in elderly patients on indications.
Use in children
Use in children and adolescents under the age of 18 is contraindicated.
Nosology (ICD codes)
F07
Personality and behavioural disorders caused by disease, damage or brain dysfunction
F45.3
Somatoform dysfunction of the autonomic nervous system
G45
Transitory cerebral ischemic attacks [attacks] and related syndromes
G93.4
Encephalopathy unrefined
H31.1
Vascular degeneration of the eye
H35.0
Background retinopathy and retinal vascular changes
H81.0
Ménière's disease
H81.1
Benign paroxysmal dizziness
H81.3
Other peripheral dizziness
H93.0
Degenerative and vascular ear disease
I63
Brain infarction
I69
Effects of cerebrovascular disease
N95.1
Menopause and Menopause in Women
N95.3
Conditions associated with artificially induced menopause
T90
Effects of head injuries
Pharmacological effect Vinpocetine:
Agent that improves cerebral blood circulation and brain metabolism. Inhibits the activity of phosphodiesterase, which contributes to the accumulation in the tissues of cAMP. It has vasodilating effects mainly on the vessels of the brain, due to direct myotropic spasmolytic action. The system AD decreases slightly.
It improves blood supply and microcirculation in brain tissues, reduces platelet aggregation, and promotes normalization of blood rheological properties. It improves hypoxia tolerance by brain cells, promoting oxygen transport to tissues by reducing erythrocyte affinity, enhancing glucose uptake and metabolism. Increases the content of catecholamines in brain tissues
